Latest News

New research shows that while niacin added to statin therapy increases HDL cholesterol levels it does not improve HDL functionality

While two large clinical trials recently showed that adding niacin to statin therapy failed to improve clinical outcomes despite a significant increase in HDL-C levels, little is known about exactly why the increased HDL-C levels did not reduce the risk of cardiovascular events, including heart attack and stroke. Now, a small study has shown that while niacin increased measured levels of HDL-C, it did not improve the functionality of HDL. This may provide an explanation for the failure of niacin to further reduce cardiovascular risk.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Hormone known for mother's milk also fosters bond between parents

  • Early education narrows the achievement gap with younger starts and longer stays

  • Stereotypes persist that class, privilege determine intellect and success

  • New gene involved in hereditary neuroendocrine tumors identified

  • Marketing of energy drinks placed on TV channels that appeal to teens

  • In Alzheimer's mice, memory restored with cancer drug

  • Bullying by students with disabilities reduced by social-emotional learning

  • Age matters: Discovering why antidepressants don't work well for kids

  • Genetic variability in the platelet linked to increased risk for clotting

  • The rapid rise of human language

  •